Related Experiment Videos

High-dose cyclophosphamide treatment for refractory severe aplastic anemia in children

Anthony N Audino1, Julie Blatt, Benjamin Carcamo

  • 1Akron Children's Hospital, Akron, Ohio, USA.

Pediatric Blood & Cancer
|October 15, 2009
PubMed

Insights

High-dose cyclophosphamide shows promise for children with severe aplastic anemia (SAA) refractory to other treatments. Two of five pediatric patients achieved complete response, indicating potential efficacy in this challenging condition.

Area of Science:

  • Pediatric Hematology
  • Oncology
  • Immunosuppressive Therapy

Background:

  • Severe aplastic anemia (SAA) involves hematopoietic precursor depletion, leading to life-threatening complications.
  • Hematopoietic stem cell transplant (HSCT) is preferred for SAA if an HLA-matched donor is available.
  • Immunosuppression with anti-thymocyte globulin (ATG) and cyclosporine A (CSA) is an alternative, but high-dose cyclophosphamide use in pediatric SAA is limited.

Purpose of the Study:

  • To evaluate the efficacy of high-dose cyclophosphamide in pediatric patients with refractory severe aplastic anemia (SAA).

Main Methods:

  • Five pediatric patients with SAA, previously unresponsive to immunosuppressive therapy, received high-dose cyclophosphamide (45 mg/kg/day for 4 days).

Main Results:

  • Two out of five patients achieved a complete response after 12 months of treatment.
  • Complete responders demonstrated red cell and platelet recovery.
  • One patient did not respond, and two patients died from infections.

Conclusions:

  • High-dose cyclophosphamide can induce complete responses in pediatric SAA patients who have not responded to standard immunosuppressive treatments.
Abstract

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...